#ryan has also had a number of high profile ad campaigns he's shot this year

[tinyshe]

[remember to save and share as this information is being suppressed and censored]

Awareness Foundation COVID-19 Roundtable

Story at-a-glance

The Awareness Foundation COVID-19 Roundtable is a sign of wakefulness and hope during times of censorship and suppression

It includes honest opinions and expertise from 14 high-profile doctors, including myself, with a focus on the potential dangers being posed by the experimental mass COVID-19 vaccination campaign

Experts discuss how COVID-19 vaccines may cause a coming tsunami of hospitalization and deaths, along with debilitating chronic disease, early signs of which are already appearing

All agree that there’s enough evidence to halt the global COVID-19 vaccination campaign, either for everyone or — particularly — for those to whom the vaccines pose the greatest risks with little to no benefit, namely children and young people, pregnant women and those who have already recovered from COVID-19

In this time of extreme censorship and suppression of scientific debate, The Awareness Foundation COVID-19 Roundtable,1 hosted by Katherine Macbean of the Awareness Foundation, is a sign of wakefulness and hope. It includes honest opinions and expertise from 14 high-profile doctors, including myself, with a focus on the potential dangers being posed by the experimental mass COVID-19 vaccination campaign.

Each has faced censorship when speaking out, and though there are some differing viewpoints, all agree that there’s enough evidence to halt the global COVID-19 vaccination campaign, either for everyone or — particularly — for those to whom the vaccines pose the greatest risks with little to no benefit. This includes children and young people, pregnant women and those who have already recovered from COVID-19.

I highly recommend setting aside two hours to watch this roundtable discussion in full — it’s a rarity in the present day to hear such candor and open debate. However, I’ve also compiled some of the highlights below, which include warnings about the dangers these experimental vaccines may pose to society.

A Tsunami of Chronic Disease and Death

Will COVID-19 vaccines cause a coming tsunami of hospitalization and deaths, along with debilitating chronic disease? One expert on the panel, Dr. Peter McCullough, an internist, cardiologist, epidemiologist and full professor of medicine at Texas A&M College of Medicine in Dallas with a master's degree in public health, said he’s focused more on the short-term adverse effects from the shot. These nonfatal injuries fall into four major categories:

Neurologic

Immunologic

Hematologic

Cardiac

“What I'm seeing is just the late emergence of various neurologic syndromes. And it probably depends on where the seeding occurs of, uh, of, you know, the uptake of the genetic material in the brain or support cells in the brain, but there's a whole variety of cerebral, cerebellar, even peripheral nervous system abnormalities,” McCullough said, adding:2

“I've seen it in my clinic and they seem to be emerging three, four or five, six months later after vaccination … So I'm getting increasingly alarmed here that this is not just a simple one- or two-day problem. And so there's great concern, particularly in younger kids that over a course of three or six or nine months, they'll end up with heart failure or cardiac death.

… What I see is, potentially from these signals, not mass death, but just a large number of Americans and people around the world with a new chronic disease of some sort of neurodegenerative disease or cardiac disease. The patients that I'm aware of, these problems seem to be quite disabling.”

Another panel member, Dr. Vladimir Zelenko, who has treated thousands of COVID-19 patients using hydroxychloroquine (HCQ), azithromycin and zinc sulfate,3 with great success, has a different take. He believes there is a very distinct possibility that everyone who receives the COVID jab may die from complications in the next two to three years:4

“I'm just going to give you the perspective of a clinician who deals with people that are dying … 4 million dead people can testify to the unique clinical syndrome to put them there. Basically, a natural animal virus was changed to infect humans, and then its lethality was augmented to cause blood clots and lung damage.

And in concept here, we're dealing with a Hitler/Stalin type of mentality with weapons of mass destruction and the way to win this war — and it's very winnable — is in the following manner. It's a narrative war. So we need to spread the following two ideas … Don't give into the fear and choose to destroy yourself, No. 1. No. 2, treat your problem early. If these two ideas could penetrate the fixed calls of humanity, then it's really the end of this crisis.”

Dr. Tess Lawrie, whose company The Evidence-Based Medicine Consultancy has worked with the World Health Organization, agreed that the vaccines are unsafe for children and adults alike:5

“They're actually not safe for anybody, and it's clear. The databases are screaming. The databases are early warning systems, and the databases around the world are screaming that we are facing a tsunami of chronic disease.”

Inflammatory Disorders, Cancer Markers on the Rise

Dr. Richard Urso, an ophthalmologist in Houston, Texas, is also concerned:6

“Early on, we were seeing things, mostly thrombotic, but later, as we get into two and three months [after vaccination], we’re seeing a lot of inflammatory issues. I’ve had a host of people with inflammatory ocular disorders, as well as having orbital inflammatory diseases.

I typically don’t see this rash number of people. For people who don’t know, my clinical practice is probably one of the largest in the United States, if not the largest, and we get a tremendous number, in volume, of patients who come through our office. And I’m seeing late inflammatory disease, and it responds quite well to inflammatory medicines.”

Some have brushed off the notion that the virus could be a bioweapon because it didn’t cause sudden, mass deaths. But this is a misconception. A successful bioweapon can be something that causes long-term, progressive, chronic-type diseases, noted Dr. Richard Fleming, a physicist, nuclear cardiologist and attorney.

In 1994, Fleming introduced the theory of inflammation and vascular disease, which explains why these inflammable thrombotic diseases, and the causes, including viruses like SARS-CoV-2, produce disease states like COVID-19.

“As I laid out in the theory in 1994,” Fleming said, “you're going to see an inflammable thrombotic response. That’s the primary thing that people are noticing, be that heart disease or retinol disease.” The other factor is a prion component of this virus, “which is also a chronic smoldering disease.” Fleming noted:7

“If you're going to actually develop something that's going to have a massive effect on your ‘enemy,’ your goal isn't to kill the enemy any more than it was the goal of the United States in Vietnam to kill the enemy.

The goal was to maim the enemy so that more of the enemy would be taken off the field. What we've seen is something that's been implemented that is an ideal by a weapon designed to demoralize and to feed people the enemy, and to cause a slow smoldering process.”

Fleming cited data from Pfizer that showed in the 12 to 14 days following the second injection of the Pfizer mRNA vaccine, elderly individuals had a 2.6-fold increase in symptoms of Alzheimer’s disease. “This is an inflammable thrombotic process affecting every organ system and prion diseases that not only affect the brain, but also affect the heart and other vital organs of the body.”8

Dr. Ryan Cole, a Mayo Clinic-trained, triple-boarded pathologist, also said that he’s seeing potential cancer-causing changes, including decreases in receptors that keep cancer in check, and other adverse events post-vaccine:9

“I’m seeing countless adverse reactions … it's really post-vaccine immunodeficiency syndrome … I'm seeing a marked increase in herpetic family viruses, human papilloma viruses in the post-vaccinated. I'm seeing a marked uptick in a laboratory setting from what I see year over year of an increase of usually quiescent diseases.

In addition to that — and correlation is not causation — but in the last six months I have seen — you know, I read a fair amount of women's health biopsies — about a 10- to 20-fold increase of uterine cancer compared to what I see on an annual basis. Now we know that the CD8 cells are one of our T-cells to keep our cancers in check.

I am seeing early signals … what I'm seeing is an early signal in the laboratory setting that post-vaccinated patients are having diseases that we normally don't see at rates that are already early considerably alarming.”

Do the Vaccinated Pose a Risk to the Unvaccinated?

Sherri Tenpenny has heard thousands of anecdotal reports that something is being transmitted from the vaccinated to the unvaccinated:10

“We're injecting a synthetically made messenger RNA and strips of synthetically made double-stranded DNA by different mechanisms, and if that transmission goes to the other person, they don't get COVID, they don't get COVID symptoms that we typically recognize as COVID. They get bleeding, they get blood clots, they get headaches, they get heart disease, they get all of these different things.”

Dr. Robert Malone, the inventor of the mRNA and DNA vaccine core platform technology,11 doesn’t agree that anything is being “passed” from vaccinated people to others, adding that while it may be possible for mRNA to be shed through breast milk to nursing infants, possibly causing gastrointestinal symptoms, anything else is just speculation.

Others suggest it could be more of a hormonal or pheromonal issue than some type of “shedding,” which may help explain why women are also reporting abnormalities with their menstrual cycles following vaccination. Dr. Lee Merritt, an orthopedic and spinal surgeon, brought up a 2015 report by the U.S. Food and Drug Administration, which looked at “shedding” in mRNA vaccines, which they call gene therapies.12 She explained:13

“They talk about, they're very concerned about the shedding — and they do call it shedding, whether that's technically correct … And they tell you in this thing who to protect, they tell you to protect neonates, immunocompromised people and elderly with bad immune systems.

They also say, we don't know what's being shed. They say it could be genetic material. It could be activated viruses and it could be a recombinant product. This is what's in the FDA data.”

Immediately Halt the Vaccine Program

All of the experts agreed that evidence suggests the mass COVID-19 vaccination program should be halted. “There is enough evidence now just from the European Medicines Agency alone, 1.7 million in reported adverse events and 17,000 deaths that the four clinical trials should be stopped,” said Dolores Cahill, a professor at the school of medicine at the University College Dublin.

“They are detailed in the classifications, cardiac related immune, uh neuropathological and fertility associated.

So I think we all have duties as doctors and scientists to say, if something is causing more harm than good, which this clearly is, we should, I think, unify and called for a stop to the clinical trials worldwide, and also that any individual prime ministers and regulators that continue the trial would have to be liable for any adverse events.”

Malone believes that the vaccines have merit for certain populations, namely the elderly, but is advocating for prohibition on vaccination for infants and newborns, through young adults up to ages 30 to 35. “And specifically,” he said, “I'm trying to stop this crazy effort to force universities and schools to have universal vaccination.” In addition, he added:

“We can argue about risk-benefit for elderly, but the risk-benefit ratio for newborns through young adults is explicitly clear. It is upside down. It's not subtle there. You're going to kill more. And, and personally, I also feel that we can dig in really hard on the reproductive health in pregnancy, in women, that there just aren't data to support the use of this product because of the potential female reproductive health consequences.”

Dr. Urso added the other significant population that has far more to risk than gain from vaccination: the COVID-recovered. “The immune status should be more important than the vaccination status,” he said.

“So I think there's three groups that are easily winnable arguments [to avoid vaccination]: pregnant women, the young and … the COVID recovered … I mean, that's a, that's a lousy thing to do to get all these people that are COVID recovered, good immune status and give them a vaccination for something they don't need.”

How to End Fear and Optimize Your Immune System

The roundtable participants are planning to continue their discussion offline to formally request an end to mass COVID-19 vaccination for the mentioned groups as well as create a statement to end government interference with the practice of medicine. Many physicians have had their hands tied when it comes to prescribing early treatments for COVID-19, like ivermectin. As Fleming noted:

“… The reason why people die with COVID is because they're not receiving treatment, so I would argue that we need to make certain that people, the physicians, are allowed to treat without government interference and that we put a hold on the dissemination of the vaccines at this point in time, until we can further investigate them safely.”

Dr. Sam White, whose reputation has been under attack since he released a video on social media detailing his concerns about the suppression of the science around therapeutics in the U.K., added:

“We could end the fear overnight by allowing access to therapeutics and changing the mainstream media narrative that there's no need for masks. There's no need for lock downs. This is more treatable than flu, as far as I'm concerned, we're just not allowed to do any treatment. If the public knew that it changes the narrative overnight.”

While we work on changing the narrative, or at least opening up discussions of science outside of the narrative, it’s always a good idea to optimize your immune system.

Toward this end, I recommend optimizing your vitamin D levels to 60 to 80 nanograms per milliliter and improving your metabolic flexibility so your body can seamlessly transition between burning fats and glucose as your primary fuel. One way to do this is to condense your eating window to about six to eight hours a day.

Even without changing your calories, this can make a profound difference, but from a perspective of choosing the right foods, one of the most important strategies that I’ve learned over my four decades of studying this is to avoid processed foods, nearly all of which are loaded with vegetable, or seed, oils.

These oils have a high content of linoleic acid, which contributes to mitochondrial instability and increases susceptibility to oxidative stress. This, in turn, increases immune dysfunction and mitochondrial dysfunction. These are simple strategies I recommend, as they're useful to improve your overall health and resiliency to fight any infection.

As mentioned, I highly recommend listening to the discussion in full to get all of the details that weren’t included here. At the next meeting, the group plans to discuss how to move forward to challenge the narrative in greater detail, including fighting back against the organizations, such as the Wellcome Trust and the Bill & Melinda Gates Foundation, that are heavily investing in this.

[fullspectrum-cbd-oil]

Factbox: Four Republicans, 18 Democrats Vie for U.S. Presidential Nominations

The largest field of Democratic presidential candidates in the modern U.S. political era got a bit smaller on Thursday when U.S. Representative Tim Ryan dropped out of the race, after failing to gain traction in opinion polls.

Ryan, 46, a moderate from a blue-collar district in northeastern Ohio, is the latest Democrat to end a bid for the party’s nomination to take on President Donald Trump, the likely Republican nominee, in the November 2020 election.

Eighteen Democrats are still vying for the nomination, and three Republicans are making a long-shot challenge to Trump’s renomination. The latest to enter the Republican race is former U.S. Representative Mark Sanford of South Carolina, who announced his bid on Sept. 8.

The diverse group of Democrats includes six U.S. senators. A record five women are running, as well as black, Hispanic, Asian and openly gay candidates who would make history if one of them becomes the party’s nominee.

A top tier of contenders has emerged from the crowded field, while others are still trying to break through. (Here is a graphic https://ift.tt/30cpPUK of the Republican and Democratic presidential fields.)

DEMOCRATIC TOP TIER

Here are the Democrats who are ranked in the top five in Reuters/Ipsos polling:

JOE BIDEN

Biden, the early front-runner in opinion polls among Democratic presidential contenders, waited until late April to enter the race, launching his bid with a direct swipe at Trump. Biden, 76, served eight years as President Barack Obama’s vice president and 36 years in the U.S. Senate. He stands at the center of the Democratic debate over whether the party’s standard-bearer should be a veteran politician or a newcomer, and whether a liberal or a moderate has a better chance of defeating Trump. Biden, who frequently notes his “Middle-Class Joe” nickname, touts his working-class roots and ability to work in a bipartisan fashion. He has faced criticism from some fellow Democrats for his role in passing tough-on-crime legislation in the 1990s.

ELIZABETH WARREN

The 70-year-old U.S. senator from Massachusetts is a leader of the party’s liberals and a fierce critic of Wall Street who was instrumental in creating the federal Consumer Financial Protection Bureau (CFPB) after the 2008 financial crisis. Her campaign has surged in recent weeks, tying or leading Biden in some polls. She has focused her presidential campaign on a populist economic message, promising to fight what she calls a rigged system that favors the wealthy. She has released an array of policy proposals on everything from breaking up big tech companies to implementing a “wealth tax” on the richest Americans. Warren has sworn off political fundraising events to back her campaign.

BERNIE SANDERS

The U.S. senator from Vermont lost the Democratic nomination in 2016 to Hillary Clinton but is trying again. For the 2020 race, Sanders, 78, is fighting to stand out in a field of progressives running on issues he brought into the Democratic Party mainstream four years ago.

Sanders suffered a heart attack while campaigning in Nevada in October, but there has been little impact so far on his support.

His proposals include free tuition at public colleges, a $15-an-hour minimum wage and universal healthcare. He benefits from strong name recognition and an unmatched network of small-dollar donors.

PETE BUTTIGIEG 

The 37-year-old mayor of South Bend, Indiana, emerged from virtual anonymity to become one of the party’s brightest stars, building momentum with young voters. A Harvard University graduate and Rhodes Scholar at the University of Oxford, he speaks seven languages conversationally and served in Afghanistan with the U.S. Navy Reserve. He touts himself as representing a new generation of leadership needed to combat Trump. Buttigieg would be the first openly gay presidential nominee of a major American political party.

KAMALA HARRIS 

The first-term U.S. senator from California would make history as the first black woman to gain the nomination. Harris, 55, the daughter of immigrants from Jamaica and India, announced her candidacy on the holiday honoring slain civil rights leader Martin Luther King Jr. She supports a middle-class tax credit, the Green New Deal and marijuana legalization. Her track record as San Francisco’s district attorney and California’s attorney general has drawn scrutiny in a Democratic Party that has grown more liberal in recent years on criminal justice issues. She saw a significant bounce in the polls after a high-profile clash with Biden over race issues during the first Democratic debate in June but has since seen her numbers drop back down.

TRYING TO BREAK THROUGH

The field also includes many Democrats who are looking for a way to break through. Some hold public office and managed to generate an early fundraising base, while others are still trying to raise their profiles.

ANDREW YANG

The entrepreneur and former tech executive is focusing his campaign on an ambitious universal income plan. Yang, 44, wants to guarantee all Americans between the ages of 18 and 64 a $1,000 check every month. The son of immigrants from Taiwan, Yang supports the Medicare for All proposal, which is based on the existing government-run Medicare program for Americans 65 and older, and has warned that automation is the biggest threat facing U.S. workers. His campaign has released more than 100 policy ideas, including eclectic proposals like creating an infrastructure force called the Legion of Builders and Destroyers. He lives in New York.

AMY KLOBUCHAR

The U.S. senator from Minnesota was the first moderate in the Democratic field vying to challenge Trump. Klobuchar, 59, gained national attention when she sparred with Brett Kavanaugh during his Supreme Court nomination hearings last year. On the campaign trail, the former prosecutor and corporate attorney has said she would improve on the Affordable Care Act, popularly known as Obamacare, by adding a public option, and is taking a hard stance against rising prescription drug prices.

BETO O’ROURKE

The former U.S. congressman from Texas gained fame last year for his record fundraising and ability to draw crowds ahead of his unexpectedly narrow loss in the U.S. Senate race against Republican incumbent Ted Cruz. But with progressive policies and diversity at the forefront of the party’s White House nominating battle, O’Rourke, 47, has faced a challenge as a white man who is more moderate on several key issues than many of his competitors. He has increasingly turned his attention to gun control and Trump’s rhetoric about immigrants after a gunman targeting Hispanics killed 22 people on Aug. 3 in El Paso, O’Rourke’s hometown.

CORY BOOKER

Booker, 50, a U.S. senator from New Jersey and former Newark mayor, gained national prominence in the fight over Kavanaugh’s Supreme Court nomination. Booker, who is black, has made race relations and racial disparities in the criminal justice system a focus of his campaign. He embraces progressive positions on healthcare coverage for every American, the Green New Deal and other key issues, and touts his style of positivity over attacks.

MIRED AT BOTTOM OF POLLS

Several candidates are stuck at the bottom according to numerous polls, with few breakout moments so far.

TULSI GABBARD 

The Samoan-American congresswoman from Hawaii and Iraq war veteran is the first Hindu to serve in the U.S. House of Representatives and has centered her campaign on her anti-war stance. After working for her father’s anti-gay advocacy group and drafting relevant legislation, she was forced to apologize for her past views on same-sex marriage. Gabbard’s populist, anti-war approach has won her fans among the far left and the far right, and she recently engaged in a Twitter war with Hillary Clinton, whom she called the “personification of the rot” after Clinton suggested Gabbard was being groomed for a third-party run at the presidency. Gabbard, 38, slammed Trump for standing by Saudi Arabia after the murder of journalist Jamal Khashoggi.

JULIAN CASTRO

Obama’s secretary of housing and urban development would be the first Hispanic to win a major U.S. party’s presidential nomination. Castro, 45, whose grandmother immigrated to Texas from Mexico, has used his family’s personal story to criticize Trump’s border policies. Castro advocates universal prekindergarten, supports Medicare for All and cites his experience to push for affordable housing. He announced his bid in his hometown of San Antonio, where he once served as mayor and a city councilman. In the third Democratic debate on Sept. 12, Castro drew jeers from the audience for an attack on Biden that was perceived as questioning the former vice president’s memory as a way to draw attention to his age.

TOM STEYER

The billionaire environmentalist, a force in Democratic fundraising over the past decade, said in January he was focusing on his efforts to get Trump impeached and get Democrats elected to the U.S. Congress. Steyer, 62, reversed course in July, saying other Democrats had good ideas but “we won’t be able to get any of those done until we end the hostile corporate takeover of our democracy.”

JOHN DELANEY

The former U.S. representative from Maryland became the first Democrat to enter the 2020 race, declaring his candidacy in July 2017. Delaney, 56, says that if elected, he would focus on advancing only bipartisan bills during the first 100 days of his presidency. He is also pushing for a universal healthcare system, raising the federal minimum wage and passing gun safety legislation. A former business executive, Delaney is self-funding much of his campaign.

MICHAEL BENNET

Bennet, 54, a U.S. senator for Colorado, has based his political career on improving the American education system. He previously ran Denver’s public schools. Bennet is not well known nationally but has built a network of political operatives and donors helping elect other Democrats to the Senate. During the partial U.S. government shutdown in January, he garnered national attention criticizing Republicans for stopping the flow of emergency funds to Colorado.

STEVE BULLOCK

Montana’s Democratic governor, re-elected in 2016 in a conservative state that Trump carried by 20 percentage points, has touted his electability and ability to work across party lines. Bullock, 53, has made campaign finance reform a cornerstone of his agenda. He emphasizes his success in forging compromises with the Republican-led state legislature on bills to expand the Medicaid healthcare funding program for the poor, increase campaign finance disclosures, bolster pay equity for women and protect public lands.

MARIANNE WILLIAMSON

The 67-year-old best-selling author, motivational speaker and Texas native believes her spirituality-focused campaign can heal the United States. A 1992 interview on Oprah Winfrey’s show led Williamson to make a name for herself as a “spiritual guide” for Hollywood and a self-help expert. She is calling for $100 billion in reparations for slavery to be paid over 10 years, gun control, education reform and equal rights for lesbian and gay communities.

WAYNE MESSAM

Messam, 45, defeated a 16-year incumbent in 2015 to become the first black mayor of the Miami suburb of Miramar. He was re-elected in March. The son of Jamaican immigrants, he played on Florida State University’s 1993 national championship football team and then started a construction business with his wife. He has pledged to focus on reducing gun violence, mitigating climate change and reducing student loan debt and the cost of healthcare. Messam’s Twitter profile says he is still running for president, but federal records show he raised only $5 during the third quarter of 2019.

JOE SESTAK

The retired three-star Navy admiral and former congressman from Pennsylvania jumped into the race in June. Sestak, 67, highlighted his 31-year military career and said he was running to restore U.S. global leadership on challenges like climate change and China’s growing influence. Sestak said he had delayed his entry in the race to be with his daughter as she successfully fought a recurrence of brain cancer.

THE REPUBLICANS

Trump is the clear favorite to win the Republican nomination, and there has been criticism among his opponents that party leadership has worked to make it impossible for a challenger. Still, the incumbent will face at least three rivals.

DONALD TRUMP

Serving in his first term, the 73-year-old real estate mogul shocked the political establishment in 2016 when he secured the Republican nomination and then won the White House. His raucous political rallies and prolific use of Twitter were credited with helping him secure victory. After running as an outsider, Trump is now focusing his message on the strong economy, while continuing the anti-immigration rhetoric that characterized his first campaign as he vies for re-election.

JOE WALSH

A former congressman, Walsh, 57, has become a vocal critic of Trump, who he argues is not a conservative and is unfit for public office. Walsh won a House seat from Illinois as a candidate of the Republican Party’s fiscally conservative Tea Party movement in 2010, but was defeated by Democrat Tammy Duckworth in his 2012 re-election bid. After leaving Congress, he became a Chicago-area radio talk-show host.

BILL WELD

The 74-year-old former Massachusetts governor ran unsuccessfully for vice president in 2016 as a Libertarian. He has been a persistent critic of Trump, saying when he launched his 2020 campaign that “the American people are being ignored and our nation is suffering.”

MARK SANFORD

The former South Carolina congressman and longtime Trump critic lost his seat in the House last year to a Trump supporter in the Republican nominating primary. Sanford, 59, served two terms as South Carolina governor from 2003 to 2011 and served in Congress from 1995 to 2001 and from 2013 to 2019. His term as governor was marked with scandal when he admitted to traveling to Argentina to meet his mistress.

(Reporting by Ginger Gibson, Joseph Ax, Tim Reid and Sharon Bernstein; Editing by Jonathan Oatis and Peter Cooney)

from IJR https://ift.tt/2Pigbdp via IFTTT

[thrashermaxey]

21 Fantasy Hockey Rambles

Every Sunday, we'll share 21 Fantasy Rambles – formerly 20 Fantasy Thoughts – from our writers at DobberHockey. These thoughts are curated from the past week's ‘Daily Ramblings’.

Writers: Michael Clifford, Ian Gooding, Cam Robinson, and Dobber

  1. If you own Mathew Barzal, you were waiting for his next goal for a while. As in over a month. Fortunately, the Isles’ center broke his goal-scoring slump (and added an assist) on Thursday. Barzal had gone without a goal in his previous 19 games.

Barzal isn’t one to pile up the goals, as his 18 goals this season is just four fewer than his total last season. With 62 points at the moment, however, he is well short of his 85-point rookie season from last season. This could be the result of having to play the tougher matchups this season versus last season, when John Tavares was still in the fold.

Playing on the top line alongside Barzal, Jordan Eberle might have decent value at this very moment based on where he’s being used, but he’s also staring at his first sub-40-point season (lockout-shortened 2012-13 not included) in his career. (mar29)

  2. The Panthers might be out of the playoff race but that isn’t stopping Jonathan Huberdeau. Huby now has nine multipoint games during March to go with nine goals and 23 points over his last 13 games. Too bad I’ve been eliminated in the league that I own him in. Don’t you just hate it when your players cash in after you’ve been eliminated?

Evgenii Dadonov is another Panthers’ forward who has picked up the pace. Over his last 13 games, Dadonov has 19 points (6g-13a). Playing on a line with Huberdeau and Aleksander Barkov might have something to do with it. Dadonov has now surpassed last season’s point total and is just two points shy of his first 70-point season. (mar29)

  3. It’s been a down year for Rickard Rakell but he might still make it to 20 goals. It’s not the 34 goals like last season, or the 33 he scored the season before, but Rakell has piled up seven goals over his last five games.

Rakell was a recent buy-low candidate through his goalless droughts of 14, 9, 8, and 6 games, up to the point in which he had just nine goals on the season earlier this month. To justify that buy-low, his shooting percentage was at a highly unlucky 6.3 percent, but it is now up to a more respectable 9.6 percent and could still climb further.

In terms of what you can do going forward, look to Rakell as a rebound candidate as he will probably slip in next season’s fantasy hockey drafts based on his overall numbers. He was drafted at around the 70th pick in this season’s Yahoo drafts, but next season he could provide great value if he is drafted outside of the top 100. (mar31)

  4. The Cam Talbot era in Philly might be short-lived, but at least he made another start on Saturday (just his second since being acquired). Talbot allowed three goals on 30 shots in the Flyers’ 5-2 loss to Carolina.

Now that the Flyers have been eliminated, the Flyers might start Talbot one or two more times as they play out the string. With this being the second consecutive season that Talbot has posted a goals-against average over 3.00, he probably won’t be considered a starter anywhere. Instead, expect him to land as a backup or at best a timeshare somewhere. (mar31)

  5. Nick Schmaltz’ new seven-year extension with an unconfirmed cap hit of $5.85 million might seem like a lengthy extension for a player that has cracked 50 points just once in three seasons, but remember that the Coyotes coveted him enough to pay a significant price (Dylan Strome and Brendan Perlini) just to acquire him.

Regardless, he was fitting in well with his new team (14 points in 17 games) before suffering a season-ending knee injury late last December. Even though the trade may appear heavily weighted in Chicago’s favor, it’s one of those that could still work out well for both teams. Salary cap owners would likely prefer to see more sustained production before investing, though. (mar31)

  6. Kevin Fiala’s ice time is up 2:40 per game with the Wild versus what he was getting with Nashville. And yet he has just seven points in 15 contests. We expected the jump in ice time but had assumed it would come with a corresponding bump in production.

That hasn’t happened, but as fantasy owners that's the mindset we need to stick to – opportunity increases the odds of success. Just because it’s a ‘fail’ (so far) doesn’t mean we figured wrong. Next year is his fourth and I expect some magic. (mar30)

  7. So, does Ryan Strome have upside after all? I mean, obviously not the elite upside we hoped for six years ago, but fantasy-worthy upside?

Now that the Rangers have shed some top players, Strome is usually seeing about 18 minutes of ice time. This is ice time he was given during the first few years of his career and he didn’t do anything with it. Now he’s doing something.

Entering Sunday action, Strome had 18 points in his last 23 games, and nine in his last 10. Food for thought: Friday he was on a line with Vladislav Namestnikov and Lias Andersson. His next goal would be his 18th, which would set a career high. (mar30)

  8. Mackenzie Blackwood is 3-8-0, 2.90 and 0.901 over his last 11 games. He’s 22, a high draft pick and has bounced back in this his third pro season after having it rough during his first two. I’m not yet ready to write him off as a potential starter for the long term but this year is the most he has played as a pro (40 combined games). (mar30)

  9. Andreas Athanasiou scored his 30th goal this past Friday. Unfortunately, the assists haven’t really been there for this year because he’s often placed on a line with the likes of ‘Tommy Stonehands’ and ‘Jimmy Lunchpail’ – for example, his linemates on Friday were Luke Glendening and Taro Hirose.

When he hits his prime in a couple of years, though, the Red Wings should have the talent around him upgraded by that point. Next year, I see another small step forward, perhaps hitting 60 (if anyone does on this team besides Dylan Larkin, it should be him) before his big jump in his sixth campaign. (mar30)

Elsewhere, the early results for Detroit’s undrafted NCAA foray this year are in. Entering Sunday action, 22-year-old Ryan Kuffner was pointless and minus-2 in six games. He had 96 points in his last 67 games with Princeton, as Max Veronneau’s (now with Ottawa) sidekick. Taro Hirose, also after six outings, saw a five-game assist streak come to an end on Friday. Hirose didn’t have a Veronneau to play with at Michigan State and to me has the higher upside. He’s been averaging about 15 minutes per game to Kuffner’s 10, so you know coach Jeff Blashill sees it the same way. (mar30)

  10. Hawks’ Alex DeBrincat now has 41 goals – that places him in the league’s top-10 in goal scoring. Not bad for a 21-year-old in just his second NHL season and who many teams thought was too small. DeBrincat is not averse to slumps, though, as he was pointless during a six-game streak before hitting the scoresheet again late this past week. (mar29)

* Don’t forget to download your Playoff Draft List. released this Friday, April 5.

If you bought the Ultimate Fantasy Pack in the summer, this will be included in that purchase. It is not included in the Keeper Fantasy Pack.

11. Leon Draisaitl also scored goal number 47 this week, which has him four behind Alex Ovechkin in the Rocket Richard Trophy race. Both Connor McDavid and Draisaitl have now hit 100 points and are in the top-5 in scoring. You’d think that would set the Oilers up nicely for a playoff spot, right? Of course not. You need an entire team, not just a couple of top-end players. The same theory applies in fantasy. (mar29)

  12. Dustin Byfuglien finally returned to the Jets’ lineup on Saturday, logging 24 minutes of ice time. Big Buff had missed the past month and a half with an ankle injury. In fact, he has been held to just 38 games this season, so it appears that playing a physical style for a decade has finally caught up to him.

Byfuglien could be in for a bounceback next season if he can stay healthy most of the time, but I’d be weary of drafting him as high as he has been in recent seasons. He averaged as the 40th pick in Yahoo drafts last fall, but I’d suggest waiting at least another round or two for the multicategory beast next season. (mar31)

  13. It was Happy Quinn Hughes day last Thursday in Vancouver, as the seventh overall pick in last summer’s NHL Entry Draft made his NHL debut. He was paired with the recently-resurgent Luke Schenn in just over 15 minutes of ice time. For fantasy owners who were lightning-fast in adding Hughes to their lineups, he recorded his first NHL point by assisting on Brock Boeser’s second-period goal. Hughes did much of the work on the goal, hopefully giving us a preview of things to come.

No first-unit power-play duty for Hughes (in that game), as the Canucks went with a four-forward first unit with Alex Edler on the point as per usual. However, 3-on-3 overtime with Hughes, Boeser, and Elias Pettersson was a sight to behold. Amazing stuff. (You can also check out Hughes' profile on Dobber Prospects.)

Elsewhere, with Thatcher Demko in net, the Canucks’ roster on Thursday provided a real glimpse into the future. Demko stopped 37 of 39 shots in earning his second win in three games. It looks like the Canucks will alternate between Demko and Jacob Markstrom the rest of the way, so plan accordingly. (mar29)

  14. Following three straight 30-point seasons and back-to-back 35-point seasons, things were looking bright for Colton Parayko heading into 2018-19. The team added names like Ryan O’Reilly, Patrick Maroon, David Perron, and Tyler Bozak, giving them loads of scoring depth. With Parayko’s stout peripheral production, a 40-point season would have made him a top-10 multicategory defenceman.

That didn’t come to pass, obviously, as Parayko sits with 26 points in 78 games. His peripherals and plus/minus have meant a solid fantasy season, but he’s still yet to attain anywhere close to his ceiling. The problem is his assists, as he has managed just 16 total thus far, and just two primary assists at five-on-five. Among 114 defenseman with at least 1000 minutes played at five-on-five, he has the fourth-lowest primary assist rate.

Parayko will be in tough to reach his ceiling now that he’s apparently third in line for power play minutes. It doesn’t mean he can’t be very valuable in fantasy leagues. With the Blues loaded with both rising and established stars, and Parayko due for a rebound in his assists next year, it seems very possible he’s a top-10 blue liner in multicategory leagues in a year’s time. (mar28)

  15. Sergei Bobrovsky is showing up when it matters most – for his squad and for his fantasy owners. Much has been said about the pending unrestricted free-agent and the likely anchor of a contract he may sign on July 1. Well, the two-time Vezina winner has been near the top of the heap for the last three months.

Stretching back to the beginning of February, Bobrovsky is 16-7-0 with six shutouts and his season save percentage is now up to .912. He’s had a few clunkers mixed in there but the overall theme is positive.

He remains a tier one guy heading into 2019-20 – especially if he finds himself on a contender next fall. (mar27)

  16. If I’m sitting down to draft a one-year league next fall, I’m pencilling Jordan Binnington into a tier-2 position. I feel that’s as aggressive as anyone should be. We’re constantly burned by the masked men, that drinking the kool-aid too quickly will send you on a not so welcoming trip. (mar27)

  17. Darcy Kuemper continues to be a rock for the desert dogs. This season could've easily been a write-off for Arizona when Antti Raanta went down in November, but thanks to Kuemper, the Yotes still have a slim shot at some playoff revenue. He's posted a quality start in 35 of 52 outings, while his 0.922 save percentage on the year is top-5 amongst ‘regular starters’.

Kuemper’s value lies at this moment, as we won't be seeing him earn this amount of starts next year. That is unless we see a team make a play for the 28-year-old via trade. He makes 1.8 million next season before hitting unrestricted free agency. (mar27)

  18. Reports came out last Tuesday that Hurricanes prospect and Hobey Baker finalist, Adam Fox, will return to Harvard for this senior year. This could a big blow for the Hurricanes, who targeted Fox in last summer's blockbuster trade with Calgary. In fact, Fox could become a free agent in 2020 if he decides to and that would be great news for all the teams in search of a young, super offensive right-shot defender. Fox would have plenty of suitors. (mar27)

  19. To give some positivity to the realm, I’m quite enjoying the trio of Jordan Greenway, Luke Kunin and Ryan Donato. Those three have been lining up together at even-strength and on the team’s second power-play unit. All three possess decent multi-category upsides. (mar26)

  20. Former first-round selection Jared McCann is with his third organization but appears to have found a fit in Pittsburgh. McCann has great wheels, a heavy release and loads of tenacity. He’s finally cracked the second power-play unit, but 31 of his 34 points have come at even-strength or while shorthanded. There remains some intriguing upside with the 22-year-old, especially if he maintains his space in the top-six moving forward. (mar26)

  21. Petr Mrazek is yet another unrestricted free agent in the summer ahead and he’s completely revived his career. The Hurricanes were likely going to move on from him come July and now I think they’re interested in hearing what he’s looking for.

If I was GM Don Waddell, I would see if I can’t lock him in for two years at a low cap rate of perhaps under $3 million. Carolina was a destination for one of the many UFA goaltenders this summer but Mrazek is doing what he can to shut the door on that opportunity for those people such as Cam Talbot, Brian Elliott and Robin Lehner.

  Have a good week, folks!!

  from All About Sports https://dobberhockey.com/hockey-home/21-fantasy-hockey-rambles/21-fantasy-hockey-rambles-11/

[rtscrndr53704]

Kansas Democrats Are About To Show Just How Big The Anti-Trump Wave Actually Is

 Voters in Kansas’ fourth congressional district are heading to the polls on Tuesday in an unexpectedly close race. And there’s a chance they’ll send President Donald Trump a rebuke in the first federal election since he won the White House in November.

The contest is over the seat formerly held by Mike Pompeo, the tea party congressman Trump picked to run the CIA. Republicans have a considerable advantage in the district, which is home to Koch Industries, as Pompeo was re-elected by over 31 points in November. Ron Estes, the Republican state treasurer, remains the favorite to win.

However, the race appears to be closer than expected. Despite the GOP advantage, Democrat James Thompson, a civil rights attorney and Army veteran, raised about $240,000 in small donations, much of which came in the waning days of the race.

Early voting numbers, while not necessarily an indicator of final turnout, showed more enthusiasm than usual among Democrats. Perhaps emboldened by this as the election approached, Thompson openly embraced support from a group that Sen. Bernie Sanders (I-Vt.) backs.

National leaders from both parties have taken note, indicating the closeness and urgency of the race. After weeks of ignoring the surging Democratic enthusiasm in the district, the Democratic Congressional Campaign Committee on Monday gave Thompson a last-minute boost, making live calls to voters on his behalf.

Republicans dispatched high profile surrogates including Vice President Mike Pence and Sen. Ted Cruz (R-Texas) and spent nearly $120,000 in the final days of the campaign, signaling how scared they were in a race that should have never even been close. Trump himself even recorded a phone call for Estes at the last minute and tweeted his support on Tuesday morning.

Ron Estes is running TODAY for Congress in the Great State of Kansas. A wonderful guy, I need his help on Healthcare & Tax Cuts (Reform).

— Donald J. Trump (@realDonaldTrump) April 11, 2017

Trump goes full Trump in his robocall for Ron Estes in #ks04. Here's a transcript: http://pic.twitter.com/hCazA0unCN

— Alexis Levinson (@alexis_levinson) April 10, 2017

Last week, before the GOP intervention, internal polling showed Estes with only a single-digit lead, The New York Times reported on Monday.

Thompson told The Huffington Post in an interview over the weekend that even if he loses, he still considers the race to be a victory for Democrats because it shows that they can make Republican strongholds competitive.

And Democratic officials, who initially saw the race as a long-shot, finally seem to be warming to that idea.

Attempting to explain their initial reluctance to intervene, a DCCC official told HuffPost on Monday that its involvement would have been “extremely damaging” because the GOP would use it against Thompson. But the unexpected Democratic mobilization provoked a change in strategy.

“Now that the race is being nationalized, and the involvement of a national party committee can’t be used against him, we don’t want Thompson to go unprotected,” the official said, adding that the race provides an opportunity to test the party’s strategies for future elections.

The Kansas race is one of three special elections across the country where Democrats could win in places traditionally dominated by the GOP. In Georgia’s sixth congressional district, early numbers look good for Jon Ossoff, a 30-year-old running for the seat once held by Newt Gingrich that Tom Price had vacated to become secretary of Health and Human Services.

In Montana, Democrats also have a chance of picking up the House seat vacated by Ryan Zinke, a Republican tapped by Trump to lead the Department of the Interior. Republicans are concerned enough they could lose that they’ve worked to block a mail-in voting effort that would increase turnout.

Around the country, a groundswell of Democratic activism has already begun to shape state-level special elections, with Democrats making gains in traditionally Republican areas.

type=type=RelatedArticlesblockTitle=Related... + articlesList=58e6ac26e4b0ace57cc0b43a,58ea3423e4b05413bfe38f8b,58e90124e4b058f0a02f9e25

-- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

from DIYS http://ift.tt/2ovpfOC